Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours - Wikidata - wikimedia - TriplyDB

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

http://www.wikidata.org/entity/Q35994127

about

Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization Techniques to assess the proliferative potential of brain tumors.Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma.An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.EGFRvIII-targeted vaccination therapy of malignant glioma.Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.Conditional astroglial Rictor overexpression induces malignant glioma in mice Ki67 protein: the immaculate deception?Genetic alterations of human brain tumors as molecular prognostic factors.A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.Emerging insights into the molecular and cellular basis of glioblastoma.p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.p53 protein in low-grade astrocytomas: a study with long-term follow-up.MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9 Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases.Pediatric glioblastomas: a histopathological and molecular genetic study.Targets for active immunotherapy against pediatric solid tumors.P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature.What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.Prognostic markers of astrocytoma: how to predict the unpredictable?Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study.Glioblastoma: pathology, molecular mechanisms and markers.Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.Peptide-Based Cancer Vaccine Strategies and Clinical Results.Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment.Prognostic significance of cyclin A and B1 in pediatric embryonal tumors.The clinical relevance of the p53 tumour suppressor gene.Proliferative activity in human glioblastomas: evaluation of different Ki67 equivalent antibodies.Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival.

P2860

Q26822717-646359F9-4D76-484F-BAE4-2D9A8B184736 Q28082603-E8193AC6-B671-4FBE-A58E-A4DFBD478FBC Q28367119-95806B70-64CD-4FC0-9D5B-8DFF7B959D8C Q30164745-591194A3-5310-4158-8A1C-413E411BC084 Q30998003-2A609956-D02F-434D-83E2-DF31FA16E773 Q33243912-C2C28E96-9639-4653-8FEC-8CB651FA8C5D Q33437733-7F03EFA8-B1A6-4AA1-B0DC-18122ADE47E8 Q33665884-0B090968-BDD0-4644-82B5-7D4A260D2861 Q33758459-B85E48D4-CE7B-4109-ACD0-33A2F5264569 Q34069375-1F970955-8C73-4CF9-9587-2842F82B2587 Q34451068-4CD7746B-59F3-44EB-93BD-F034C17D2C9B Q34570709-0AC75340-F09D-48DB-86DA-2BC97615B60B Q35117832-CD212D47-3E26-4EB4-8EDD-FB35F4FCBD1E Q35660849-93E0136D-00F7-4CE1-8D02-BDF5CFD17F60 Q35790323-535A2A97-394C-4395-8AC4-CBA5D66CB606 Q35914897-4FEFFBEF-2250-4C9F-9B48-6F4461E09463 Q35977435-68FC11A8-332C-4259-8505-C6412CF542CB Q35978409-9851071C-5F5B-4373-9FD2-0840F5B02DA1 Q36431757-D4AAEDE1-4CFD-4132-83FE-820AE30C9FD1 Q36510801-2B301A75-58D7-4FDC-AC86-2D44001311D3 Q36618628-AF846E4A-339D-4D38-9226-DDAB61D2B22C Q36882527-DB316EF3-4D55-49EA-BC9E-92D1DFFE1E43 Q37153458-568DB766-BDB9-47B7-BBF2-623D3CC0C9A7 Q37228212-5C4A798C-F158-42AE-9BA5-BB28820D6960 Q37284256-D60F2E0A-0D1F-4382-99DC-FE6C787DE735 Q37325556-DB5C637A-BEC9-4DC2-9FAE-BEFA862A0BD0 Q37749605-39C5B2AE-0D36-4CA6-83F0-CB3E59DB2796 Q38043443-FE4AE89A-1024-49B5-B2B5-AF29C0223491 Q38089921-2DA3C385-4125-4E8B-9E1D-CF5B099A77F6 Q38172182-2384C853-45A3-4BB3-BBC6-383D4FB20945 Q38444000-7667D457-3045-4E57-AE8F-73909EF3C191 Q38460865-7D6B7EF0-17DC-45F1-B4A9-9C908303E5F3 Q38526029-08621A7D-4231-4982-BCB0-54DB46840B72 Q38807849-D7C38568-E1F8-409C-B14F-5341BE420494 Q39787378-CB46E611-E964-4680-A099-448EAAE9600A Q39818480-14B02A7A-55E7-41D6-AD24-96A1D2F5EA89 Q40627208-5CE1700A-0067-4E71-B0EF-D6852CC5412A Q40727246-792207A8-1E51-4844-A6AA-B0DCE8FA1726 Q42859305-20DA9E8B-4B01-48CC-A700-49C5E9E6D880 Q43081222-63B3E923-5541-4F95-AC8D-0787E0F8855B

P2860

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

http://www.wikidata.org/entity/Q35994127

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Prognostic implications of p53 ...... -67 labelling in brain tumours

@ast

Prognostic implications of p53 ...... -67 labelling in brain tumours

@en

type

label

Prognostic implications of p53 ...... -67 labelling in brain tumours

@ast

Prognostic implications of p53 ...... -67 labelling in brain tumours

@en

prefLabel

Prognostic implications of p53 ...... -67 labelling in brain tumours

@ast

Prognostic implications of p53 ...... -67 labelling in brain tumours

@en

P1433

Q35994127-3F71B5B3-EA96-4974-AADB-1AE755B9D372

P1476

Q35994127-B277ECD5-FBC4-45BC-A31D-278B5005D407

P2093

Q35994127-0925FAE3-9050-4863-BF6D-A50736267532

Q35994127-332F4C1C-F8B5-4C4F-A25C-387BBB51C6C5

Q35994127-53BDDDA9-7F03-4E4F-9EFD-8C2BB7CAE966

Q35994127-5461995E-544E-4116-97AA-F605652103D6

Q35994127-9372EFC0-4ECA-4B9A-966F-45601FE9EC12

Q35994127-E0520347-8337-4D51-94D5-4ABD5AC77C8B

Q35994127-E5075477-ECF8-4DEF-86DA-FAEFAFD235E7

Q35994127-F01376D5-6045-4E90-BF0A-46E9BDD3E8C8

Q35994127-F3801060-BD19-4F10-9560-089BEF65C95C

P2860

Q35994127-0339CB2A-F328-46AF-A5E9-A98A688EFE4C

Q35994127-06D9941D-DD4C-422F-B2EA-7761EE7AA16D

Q35994127-0856C295-BFC0-4120-BA70-571C78C1B371

Q35994127-0C5E5882-8E70-4861-B31C-B49A501CD278

Q35994127-1A53CDC8-9999-4DF3-9683-0AC0598B9DB1

Q35994127-1D3EB555-EB5B-4943-B2E8-882E4BA81285

Q35994127-20D74F5C-39C0-41A6-8553-63BEEE48432D

Q35994127-25403FC4-733C-4689-A2A8-45120A4BD9C8

Q35994127-25841AD2-9C8D-40B3-8060-A989D09EF449

Q35994127-320CEDF3-8160-43C0-AF32-579745F653F3

P2888

Q35994127-8E396635-8EA8-4A8E-BD3A-669D03838571

P304

Q35994127-F37587A9-4CB7-411B-B48E-B85049BD8D9A

P31

Q35994127-3F6D5AE9-C782-4757-B4E4-0A0053CB5E94

P356

Q35994127-AE3EB1A6-1BF7-4D48-8E42-F2FE9EA083D1

P407

Q35994127-7F1F0514-B187-4111-A788-E08B44040CBF

P433

Q35994127-52616B90-F43E-431E-8067-36F30CBFC396

P478

Q35994127-062FD353-84D1-41A9-B5AB-B88D22CF94ED

P577

Q35994127-2440D81C-3FF8-4E45-A5A3-FFF52D65D3F6

P5875

Q35994127-AF0BF5B7-3CA1-4CFD-AD5D-A1319A21F2DD

P6179

Q35994127-433DA524-7284-4691-B28B-0BE5C20CF0CB

P698

Q35994127-04A60F64-D62B-4C37-B1BC-490AF967D261

P932

Q35994127-B46C3516-28A8-4DA8-B31B-462006DA6B9B

P356

P1433

British Journal of Cancer

P1476

Prognostic implications of p53 ...... -67 labelling in brain tumours

@en

P2093

Adam L

http://www.w3.org/2001/XMLSchema#string

Crawford PJ

http://www.w3.org/2001/XMLSchema#string

Jaros E

http://www.w3.org/2001/XMLSchema#string

Kalbag RM

http://www.w3.org/2001/XMLSchema#string

Kelly PJ

http://www.w3.org/2001/XMLSchema#string

Mendelow AD

http://www.w3.org/2001/XMLSchema#string

Pearson AD

http://www.w3.org/2001/XMLSchema#string

Perry RH

http://www.w3.org/2001/XMLSchema#string

Sengupta RP

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the p53 gene occur in diverse human tumour types

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Mechanisms of p53 loss in human sarcomas.

p53 mutations in colorectal cancer

Mitotic recombination of chromosome 17 in astrocytomas.

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.

P2888

P304

373-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1992.273

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1992-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21651633

http://www.w3.org/2001/XMLSchema#string

P6179

1016046130

http://www.w3.org/2001/XMLSchema#string

P698

1503912

http://www.w3.org/2001/XMLSchema#string

P932

1977794

http://www.w3.org/2001/XMLSchema#string